マルタ - 英語 - Medicines Authority

ecosse limited “mangion building”, new street off valletta road, luqa, lqa 6000, malta - triamcinolone acetonide - nasal spray, suspension - triamcinolone acetonide 55 µg - nasal preparations

バーレーン - 英語 - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

yousif mahmood hussain pharmacy - triamcinolone acetonide - nasal spray - 55

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - triamcinolone acetonide - spray - 55microgram/1dose

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - triamcinolone acetonide - spray - 55microgram/1dose

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - triamcinolone acetonide - spray - 55microgram/1dose

ベルギー - 英語 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

opella healthcare belgium sa-nv - triamcinolone acetonide 55 mg/100 g - nasal spray, suspension - 55 µg/dose - triamcinolone acetonide 55 µg/dose - triamcinolone

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - triamcinolone acetonide - spray - 55microgram/1dose

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

physicians total care, inc. - triamcinolone acetonide (unii: f446c597ka) (triamcinolone - unii:1zk20vi6ty) - triamcinolone acetonide 55 ug - triamcinolone acetonide nasal spray is indicated for the treatment of the nasal symptoms of seasonal and perennial allergic rhinitis in adults and children 6 years of age and older. labeling describing use of triamcinolone acetonide nasal spray in pediatric patients 2 to 5 years of age is approved for sanofi-aventis u.s. inc.’s nasacort® aq nasal spray. however, due to sanofi-aventis u.s. inc.’s marketing exclusivity rights, a description of that use is not approved for this triamcinolone acetonide nasal spray labeling. triamcinolone acetonide should not be administered to patients with a history of hypersensitivity to triamcinolone acetonide or to any of the other ingredients of this preparation. there are no adequate and well-controlled studies of triamcinolone acetonide nasal spray in pregnant women. triamcinolone acetonide was teratogenic in rats, rabbits, and monkeys. triamcinolone acetonide nasal spray, like other corticosteroids, should be used during pregnancy only if the potential benefit justifies

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

medvantx, inc. - triamcinolone acetonide (unii: f446c597ka) (triamcinolone - unii:1zk20vi6ty) - triamcinolone acetonide 55 ug - triamcinolone acetonide nasal spray is indicated for the treatment of the nasal symptoms of seasonal and perennial allergic rhinitis in adults and children 6 years of age and older. labeling describing use of triamcinolone acetonide nasal spray in pediatric patients 2 to 5 years of age is approved for sanofi-aventis u.s. inc.’s nasacort® aq nasal spray. however, due to sanofi-aventis u.s. inc.’s marketing exclusivity rights, a description of that use is not approved for this triamcinolone acetonide nasal spray labeling. triamcinolone acetonide should not be administered to patients with a history of hypersensitivity to triamcinolone acetonide or to any of the other ingredients of this preparation. there are no adequate and well-controlled studies of triamcinolone acetonide nasal spray in pregnant women. triamcinolone acetonide was teratogenic in rats, rabbits, and monkeys. triamcinolone acetonide nasal spray, like other corticosteroids, should be used during pregnancy only if the potential benefit justifies

カナダ - 英語 - Health Canada

apotex inc - triamcinolone acetonide - spray, metered dose - 55mcg - triamcinolone acetonide 55mcg - corticosteroids